508735
research-article2013
FAIXXX10.1177/1071100713508735Foot & Ankle International
Editorial
Highlight Article: January–June 2013
With our new publisher, we have had many more online article downloads. One measure of the impact of an article is the number of downloads it has received. For January to June 2013, the clear leader was “A Comparison of Botulinum Toxin A and Intralesional Steroids for the Treatment of Plantar Fasciitis: A Randomized, Double-Blinded Study.”1 We are highlighting this article here to draw attention to some of the more important work being published by the journal. This study had a sound scientific design with its doubleblind format. In addition, it evaluated a novel treatment for plantar fasciitis, botulinum toxin injection. In the study, 19 patients received an injection of botulinum toxin into each head of the gastrocnemius with plantar fascia stretching exercises and 17 patients received an injection with dexamethasone and lidocaine into the plantar fascia origin with plantar fascia stretching exercises. At the 1-, 2-, 4-, and 6-month follow-up visits, the patients in the botulinum treatment group had significantly lower pain VAS scores and better FADI and Maryland Foot and Ankle Scores. A previous study had evaluated injecting the botulinum toxin into the plantar fascia origin and arch musculature
Foot & Ankle International 34(11) 1471 © The Author(s) 2013 Reprints and permissions: sagepub.com/journalsPermissions.nav DOI: 10.1177/1071100713508735 fai.sagepub.com
with some success. In the featured article, the treatment method of injecting the gastrocnemius is more consistent with gastrocnemius recession surgery but without the need for surgery. However the results were preliminary, with only 6 months of follow-up, but they were clearly superior to those of the steroid injection group. As evident with this article, Foot and Ankle International publishes the latest, most important research involving care of the foot and ankle. We look forward to continuing to present the most important work being done in our field. David B. Thordarson, MD Editor in Chief Foot and Ankle International Reference 1. Elizondo-Rodriguez J, Araujo-Lopez Y, Moreno-Gonzalez JA, Cardenas-Estrada E, Mendoza-Lemus O, Acosta-Olivo C. A comparison of botulinum toxin A and intralesional steroids for the treatment of plantar fasciitis: a randomized, double-blinded study. Foot Ankle Int. 2013;34:8-14.
Downloaded from fai.sagepub.com by guest on March 25, 2015
research-article2013
FAIXXX10.1177/1071100713508735Foot & Ankle International
Editorial
Highlight Article: January–June 2013
With our new publisher, we have had many more online article downloads. One measure of the impact of an article is the number of downloads it has received. For January to June 2013, the clear leader was “A Comparison of Botulinum Toxin A and Intralesional Steroids for the Treatment of Plantar Fasciitis: A Randomized, Double-Blinded Study.”1 We are highlighting this article here to draw attention to some of the more important work being published by the journal. This study had a sound scientific design with its doubleblind format. In addition, it evaluated a novel treatment for plantar fasciitis, botulinum toxin injection. In the study, 19 patients received an injection of botulinum toxin into each head of the gastrocnemius with plantar fascia stretching exercises and 17 patients received an injection with dexamethasone and lidocaine into the plantar fascia origin with plantar fascia stretching exercises. At the 1-, 2-, 4-, and 6-month follow-up visits, the patients in the botulinum treatment group had significantly lower pain VAS scores and better FADI and Maryland Foot and Ankle Scores. A previous study had evaluated injecting the botulinum toxin into the plantar fascia origin and arch musculature
Foot & Ankle International 34(11) 1471 © The Author(s) 2013 Reprints and permissions: sagepub.com/journalsPermissions.nav DOI: 10.1177/1071100713508735 fai.sagepub.com
with some success. In the featured article, the treatment method of injecting the gastrocnemius is more consistent with gastrocnemius recession surgery but without the need for surgery. However the results were preliminary, with only 6 months of follow-up, but they were clearly superior to those of the steroid injection group. As evident with this article, Foot and Ankle International publishes the latest, most important research involving care of the foot and ankle. We look forward to continuing to present the most important work being done in our field. David B. Thordarson, MD Editor in Chief Foot and Ankle International Reference 1. Elizondo-Rodriguez J, Araujo-Lopez Y, Moreno-Gonzalez JA, Cardenas-Estrada E, Mendoza-Lemus O, Acosta-Olivo C. A comparison of botulinum toxin A and intralesional steroids for the treatment of plantar fasciitis: a randomized, double-blinded study. Foot Ankle Int. 2013;34:8-14.
Downloaded from fai.sagepub.com by guest on March 25, 2015
